🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A meaningful funding injection to help us realise our goals ! Thanks MTPConnect and our partners Planet Innovation Baker Institute Swinburne University of Technology

Our capital raising effort continues and we still require further investment, but our $750K TTRA Project funding is a huge boost !

In today's Biotech Dispatch ... biotechdispatch.com.au/news/nirtek-be… Collaboration is key. Thanks; Planet Innovation MTPConnect Medical Device Partnering Program Baker Institute Swinburne University of Technology MedTech Actuator MicroNanoResearch AusBiotech

Integrated Photonics and Applications Centre RMIT University Monash University Monash Engineering Bill_Corcoran RMIT Research Swinburne University of Technology We're helping to detect heart attacks before they happen with Nirtek with a tiny sensor powered by light to combat one of the leading causes of death worldwide. rmit.edu.au/research/centr… /6

A Baker Institute spin-off company, NIRTEK, has been established to detect heart attacks before they happen. The researchers are using a tiny sensor powered by light to combat one of the leading causes of death worldwide. Read more 👉 medicalresearchdiscoveries.org.au/stories/start-…

linkedin.com/feed/update/ur…

🎧Stay tuned for our next podcast episode with Nirtek CEO Matthew Hoskin on developing the first intra-coronary guidewire device to detect unstable plaques & prevent heart attacks. Our TTRA program awarded funding to Nirtek in 2021 & provides support from Medical Device Partnering Program.

NEW PODCAST: To prevent heart attacks, Nirtek is developing the 1st intra-coronary guidewire device to detect unstable plaques. Caroline Duell & Lauren Eve Kelly meet CEO Matthew Hoskin to find out how TTRA funding & Medical Device Partnering Program support makes a difference. apple.co/3AfsbUw

Cardiac digital twins and AI together to identify optimal sites for radioablation of arrhythmia-causing accessory pathways. Brilliant work presented by NataliaTrayanova at the #gco2022. Inspiring work that’s complimentary to what we’re doing at Nirtek to prevent heart attacks.

Development of our NIRAF device has been helped by some terrific biomedical engineering and optical physics work performed by #medtechvic sponsored intern, Toon Goris. swinburne.edu.au/news/2022/08/i…

Our Chair, Sue MacLeman is chairing the session ‘How Not to Get Lost in Translation’, with our four TTRA Round 1 awardees, Jo-Anne Manski-Nankervis, Matthew Hoskin Tracey Gaspari & Dr Edith Holloway at the Australian Centre Accelerating Diabetes Innovation Partnering Summit on #WorldDiabetesDay2022.

Our CEO Matthew Hoskin joined some impressive leaders to talk about how not to get lost in the translation of medical devices from research to the clinic. Thanks to Australian Centre Accelerating Diabetes Innovation for hosting a terrific summit on World Diabetes Day.

The patent for our guidewire for detection of unstable coronary plaques just been granted in Australia ! Specific to the device design, this new patent provides additional protection to our first patent for NIRAF, which is already granted in the USA & Japan and accepted in EU.

Our #TTRA team visited Melb-based Medtech start-up Nirtek & its new project partner Exa Product Development, for an uplifting discussion & demo of Nirtek’s guidewire device for the detection of unstable coronary plaque to prevent heart attack & death.

Nirtek CMO Prof. Karlheinz Peter describes the medtech device we're developing to detect unstable coronary plaques before they rupture and cause a heart attack. #medtech Baker Institute Swinburne University of Technology AusBiotech MTPConnect

Our CEO & Chair Hon Hon. Jaala Pulford were delighted to visit Neo Bionica CEO Dr Ludovic Labat. Great hearing about their work taking medtech ideas into clinical reality through advanced engineering & manufacturing, especially their work w Nirtek, backed by our TTRA program!

The next generation of #medtech breakthrough products were on display this week at #LSIEurope23 where our CEO Matthew Hoskin presented Nirtek.

🚨New case study! Funded by our TTRA program & the 1st awardee to complete its research project, Nirtek is developing the NIRAF Guidewire, a smart diagnostic device to detect & rapidly treat unstable plaque & prevent heart attack. 🫀 Find out more bit.ly/3FXxFou

With Australian Stroke and Heart Research Accelerator on 8 Dec, we co-hosted its 2023 Partnering Summit which focused on Partnering for Research Translation. #TTRA Research Projects Nirtek & University of Sydney presented & our CEO Stuart Dignam welcomed everyone. #ASHRASummit Read more 🫀🔬bit.ly/41uyBKU

Pleased to have Channel 7 feature Nirtek in their TTRA round 2 story. Having received great support from MTPConnect to get us where we are, we’re now seeking funding to complete the final piece of R&D and conduct our first in-human trial.